We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

CACNA1C rs16929277: Sleep Latency & Sleep Quality

rs16929277
Trait
Limited evidenceGene: CACNA1C

The rs16929277 single nucleotide polymorphism is an intronic DNA variant located within the CACNA1C gene on chromosome 12. Emerging genome-wide and candidate-gene association studies have tentatively linked this variant to variations in subjective sleep latency—how long it takes to fall asleep—and perceived sleep quality. However, because scientific evidence remains limited, this variant should be viewed as an exploratory genetic marker rather than a diagnostic indicator.

What each genotype means

C/CLower attention

Typical sleep latency profile

This genotype represents the more common variant at this location in many populations. Research into CACNA1C suggests that variations in this gene may influence sleep architecture, though the specific impact of this intronic variant on your personal sleep latency remains limited and requires further study. Please note that sleep quality is influenced by many genetic and environmental factors.

This genotype is common globally, reflecting the high minor allele frequency of the T variant in the general population.

C/TLower attention

Varied sleep latency profile

Carrying one copy of each allele means you have a heterozygous genotype for this variant. While CACNA1C is known to modulate electrophysiological rhythms during sleep, the evidence linking this specific intronic variant to subjective sleep quality is currently limited. You should view this as a minor genetic factor among many that contribute to individual sleep patterns.

This heterozygous genotype is frequently observed, consistent with the common distribution of both C and T alleles across diverse ancestral groups.

T/TLower attention

Alternative sleep latency profile

This genotype represents the alternative homozygous state for this variant. Because CACNA1C plays a role in voltage-gated calcium channels that regulate brain activity, researchers investigate such variants for potential associations with sleep latency and quality. Current evidence is limited, and this genotype should not be considered a diagnostic indicator for sleep health.

This genotype is found in a significant portion of the population, as the T allele is common globally with a frequency of approximately 35-45%.

Understanding the Variant: What and Where Is rs16929277?

The single nucleotide polymorphism (SNP) designated as rs16929277 is situated on chromosome 12 within an non-coding intronic region of the CACNA1C gene. In human genetics, intronic variations do not alter the amino acid sequence of proteins directly, but they can influence how genes are regulated, spliced, or expressed across different neural tissues. The variant involves a common C-to-T transition. Because it resides in a non-coding region, its biological effects are subtle and likely interact with other nearby variants across the broad CACNA1C locus. Documented in public genomic registries like dbSNP and the GWAS Catalog, rs16929277 is routinely included on array-based genotyping platforms designed to study neuropsychiatric traits, neurodevelopment, and sleep physiology.

The Biological Role of the CACNA1C Gene

The CACNA1C gene encodes the pore-forming alpha-1 subunit of the Cav1.2 voltage-gated calcium channel. These L-type calcium channels facilitate the regulated influx of calcium ions into cells upon electrical excitation, playing a fundamental role in cardiac muscle contraction and neurotransmitter release within the central nervous system. In the brain, Cav1.2 channels are crucial for synaptic plasticity, circadian rhythms, neuronal excitability, and electrophysiological oscillation patterns. Preclinical and clinical models have demonstrated that calcium channel signaling modulates electroencephalographic (EEG) rhythms and slow-wave and rapid eye movement (REM) sleep architecture. As a result, variations throughout CACNA1C are of great interest to sleep researchers studying the neural circuitry governing rest-wake transitions.

Scientific Research: Sleep Latency and Quality Associations

Multiple studies evaluating sleep-wake regulation have identified CACNA1C as a candidate locus for sleep behavior. Research examining subjective sleep parameters has linked variations at rs16929277 with modest differences in sleep latency—the duration required to transition from full wakefulness to sleep—as well as self-reported overall sleep quality. However, the overall strength of this association remains classified as limited. Sleep latency is a multifactorial trait governed by hundreds of micro-effect genetic loci, developmental factors, stress levels, and light exposure. While large cohort studies and birth cohorts, such as the Finnish CHILD-SLEEP study, highlight the role of CACNA1C variants in sleep initiation and consolidation, effect sizes for individual SNPs like rs16929277 are very small, and findings vary across study designs and ancestral backgrounds.

Population Frequency and Allelic Distribution

The rs16929277 polymorphism is a common global variation rather than a rare mutation. Across international reference panels like the Genome Aggregation Database (gnomAD), the minor allele frequency (MAF) consistently ranges between approximately 35% and 45% across diverse continental populations, including European, East Asian, and admixed American cohorts. Because both the major and minor alleles are widely distributed, homozygous and heterozygous genotypes are frequently observed worldwide. This widespread distribution indicates that carrying the alternative allele is a normal element of natural human genetic diversity rather than an evolutionary disadvantage or pathological defect.

Actionability: What You Can and Cannot Conclude

It is critical to recognize what this genetic data cannot do: rs16929277 does not diagnose insomnia, sleep apnea, or any sleep disorder, nor does it deterministically dictate how long you take to fall asleep. Because its effect size is minor and the current evidence base is limited, an individual genotype cannot predict night-to-night sleep patterns. Environmental factors, caffeine intake, screen usage before bed, mental health, and physical activity exert far stronger influences on sleep onset than any single intronic variant. Individuals experiencing chronic daytime sleepiness, prolonged sleep latency, or non-restorative sleep should consult a qualified healthcare provider or sleep specialist for evidence-based clinical assessments, rather than relying on genetic interpretation.

How common is this variant?

The rs16929277 variant is common across diverse global populations, displaying a minor allele frequency between approximately 35% and 45% in broad reference cohorts such as gnomAD.

Frequently asked questions

Does having rs16929277 mean I have insomnia?

No. rs16929277 is not a diagnostic test for insomnia or any clinical condition. It is an intronic variant tentatively correlated with subtle variations in subjective sleep latency across population studies, but it does not cause sleep disorders on its own.

What is the CACNA1C gene?

CACNA1C is a gene that codes for a subunit of voltage-gated L-type calcium channels. These channels control calcium movement into cells, which is vital for heart contraction, brain signaling, and electrophysiological brain rhythms involved in sleep.

Can I improve my sleep latency through genetic insights?

Single genetic variants provide little actionable guidance for bedtime routines. Standard behavioral interventions—such as maintaining a consistent sleep schedule, limiting evening blue light exposure, avoiding late-day stimulants, and practicing relaxation techniques—have proven clinical efficacy that far outweighs individual genetic markers.

Why is the evidence for rs16929277 considered limited?

The association between rs16929277 and sleep traits comes from limited candidate studies and self-reported survey measures rather than universally replicated, large-scale clinical trials. Statistical findings also vary significantly across different cohorts and ancestral groups.

Sources & further reading

Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs16929277?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in CACNA1C